ABBOTT LABORATORIES
Government Contracts & Awards
Proprietary Tech & Patents
PREDICTING ANALYTE LEVELS BASED ON INTERMITTENT SENSOR DATA
Form D Funding
No recent SEC Form D filings found.
Market Intelligence & News
Abbott Laboratories Stock: Is ABT Underperforming the Healthcare Sector?
Despite Abbott Laboratories' underperformance relative to the healthcare sector over the past year, Wall Street analysts remain strongly optimistic about the stock’s prospects.
How Abbott Labs Is Embracing RFK Jr.'s Make America Healthy Again Movement
Abbott Laboratories is leaning into the Make America Healthy Movement, launching a new infant formula made with whole milk.
What Is Abbott Laboratories (ABT) Telling Investors With Its New Infant Formula?
Abbott Laboratories (NYSE:ABT) launched Similac 360 Total Care Made With Whole Milk, a commercially sterile ready-to-feed liquid infant formula made with whole milk in the U.S. The product is the first of its kind in the U.S. market to combine whole milk with a ready-to-feed liquid format. The formula uses whole milk and a blend of human milk oligosaccharides to more closely mirror key elements of breast milk. The launch expands Abbott's infant nutrition portfolio and targets parents seeking...
National Advertising Division Finds Certain Kendamil Infant Formula Claims Supported; Recommends Others Be Modified or Discontinued
In a challenge brought by Abbott Laboratories, BBB National Programs’ National Advertising Division determined that Kendal Nutricare Limited provided support for certain claims about the use of whole milk in its Kendamil infant formula. However, the National Advertising Division (NAD) recommended that Kendal modify or discontinue claims regarding the product's nutritional benefits, ingredients, and heritage.New York, NY, Aug. 31, 2026 (GLOBE NEWSWIRE) -- In a challenge brought by Abbott Laborato
Abbott Laboratories (NYSE:ABT) Clears All Quality Investing Hurdles
Discover why Abbott Labs (ABT) clears a quality screen with high ROIC, solid growth, and 96.8% profit quality. Valuation below market adds appeal.
Abbott Bypasses Appeals Process To Settle Ongoing Premature Infant Formula Litigation
Abbott Laboratories (NYSE:ABT) on Friday reached a significant agreement with three law firms to resolve the Gill lawsuit alongside claims from roughly 2,000 individuals.These disputes center around the company’s specialty infant formulas for premature babies and allegations connecting the products to necrotizing enterocolitis (NEC), a severe inflammatory intestinal disease affecting underdeveloped infants.In July 2024, a St. Louis jury delivered a $495 million verdict against the health care co
Can Abbott Laboratories (ABT)’s Instinct Sensor Give MiniMed Group (MMED) a Competitive Edge?
Two healthcare innovators, MiniMed Group, Inc. (NASDAQ:MMED) and Abbott Laboratories (NYSE:ABT), hit the spotlight this August with a milestone partnership. On August 17, MiniMed announced that its MiniMed Flex system is commercially shipping in the U.S., integrated with Abbott’s Instinct continuous glucose sensor. This collaboration marks a major leap in diabetes tech, pairing MiniMed’s smallest, […]
Recent Report Shows That Rep. Rick Allen Sold Up to $50K Worth of Abbott Laboratories Stock
An official report on August 18, 2026 reveals Representative Rick Allen's recent sale of Abbott Laboratories (NYSE:ABT) stock, valued between $15,001 and $50,000. The transaction took place on July 14, 2026, as per
Abbott Laboratories: Diagnostics And Medical Devices Fuel Next Growth Phase (Downgrade)
Abbott Laboratories is a Buy due to higher valuation, but expect low-teens annual total returns supported by strong fundamentals. Read more on ABT stock here.
Abbott Laboratories: Reasonably Valued After Surge, But Still An Attractive Buy Long-Term
Abbott stays a buy after Q2 beat/raise; Exact Sciences boosts growth. Click for more on ABT stock.
Congressional Trades in $ABT
Insider Trades (Form 4)
Roman Michael F
Gonzalez Patricia Paola
Cushman Elizabeth C.
Moreland Mary K
STARKS DANIEL J
Conroy Kevin T
Stratton John G
Roman Michael F
Key People
McDew Darren W
Director
OGrady Michael
Director
Kumbier Michelle
Director
Conroy Kevin T
Director
Ahuja Nita
Director
ORVILLE JACOB A
Senior Vice President
MCCOY JOHN A
VICE PRESIDENT AND CONTROLLER
Salvadori Daniel Gesua Sive
EVP AND GROUP PRESIDENT
Scoggins Christopher J
EXECUTIVE VICE PRESIDENT
Boudreau Philip P
EVP AND CFO
Cushman Elizabeth C
EVP, GC AND SECRETARY
Alpern Robert J
Director
Roman Michael F
Director
Earnhardt Lisa D
EVP AND GROUP PRESIDENT
Shroff Eric
Senior Vice President
Wainer Andrea F
RETIRED EVP
ALLEN HUBERT L
EXECUTIVE VICE PRESIDENT, GC
Ford Robert B
CHAIRMAN AND CEO
Gonzalez Patricia Paola
Director
Boudreau Philip P
EXECUTIVE VICE PRESIDENT
Political Giving
$435,000 given to 54 candidates across 147 disclosed contributions (FEC Schedule A).
Darin McKay LaHood
Bradley S. Schneider
Scott H. Peters
Lisa McClain
Adrian Smith
Terri A. Sewell
Gus M. Bilirakis
Virginia Foxx
James D Jordan
Diana Harshbarger
Blake Moore
Nanette Barragan
Kim Schrier
Elizabeth Fletcher
Suzan K. DelBene
Earl Leroy Carter
Katherine M. Clark
Angus King
David P. Joyce
Lori Trahan
+ 34 more recipients not shown.
Factual Connections
Connections to other companies, executives, and politicians — sourced from disclosed trades, shared officers/directors, and public filings — are a Pro/Alpha feature.
Upgrade to Pro